The most common antibodies associated with SCLC and PLE are anti-Hu and anti-Ma2, followed by anti-CRMP5, anti- GABABR, anti-PCA2, anti-AMPAR, and anti-GAD [24,25,26]. Here, PNMA2 is linked to small cell lung carcinoma.